{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:15:01Z","timestamp":1792689301004,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-86674-9","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:44:05Z","timestamp":1737506645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development and validation of a machine learning-based prediction model for hepatorenal syndrome in liver cirrhosis patients using MIMIC-IV and eICU databases"],"prefix":"10.1038","volume":"15","author":[{"given":"Fengwei","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"issue":"6","key":"86674_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang, D. Q. et al. Global epidemiology of cirrhosis\u2014aetiology, trends and predictions. Nat. Rev. Gastroenterol. Hepatol. 20(6), 388\u2013398 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"86674_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70(1), 151\u2013171 (2019).","journal-title":"J. Hepatol."},{"key":"86674_CR3","doi-asserted-by":"publisher","first-page":"m2687","DOI":"10.1136\/bmj.m2687","volume":"370","author":"DA Simonetto","year":"2020","unstructured":"Simonetto, D. A., Gines, P. & Kamath, P. S. Hepatorenal syndrome: Pathophysiology, diagnosis, and management. Bmj 370, m2687 (2020).","journal-title":"Bmj"},{"issue":"4","key":"86674_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/j.gastro.2023.11.306","volume":"166","author":"E Pose","year":"2024","unstructured":"Pose, E., Piano, S., Juanola, A. & Gin\u00e8s, P. Hepatorenal syndrome in cirrhosis. Gastroenterology 166(4), 588\u2013604e1 (2024).","journal-title":"Gastroenterology"},{"issue":"9","key":"86674_CR5","first-page":"1310","volume":"56","author":"F Salerno","year":"2007","unstructured":"Salerno, F., Gerbes, A., Gin\u00e8s, P., Wong, F. & Arroyo, V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56(9), 1310\u20131318 (2007).","journal-title":"Gut"},{"issue":"2","key":"86674_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cld.2022.01.002","volume":"26","author":"S Buccheri","year":"2022","unstructured":"Buccheri, S. & Da, B. L. Hepatorenal Syndrome: Definitions, diagnosis, and management. Clin. Liver Dis. 26(2), 181\u2013201 (2022).","journal-title":"Clin. Liver Dis."},{"issue":"2","key":"86674_CR7","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.31884","volume":"74","author":"SW Biggins","year":"2021","unstructured":"Biggins, S. W. et al. Diagnosis, evaluation, and management of Ascites, spontaneous bacterial peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the study of Liver diseases. Hepatology 74(2), 1014\u20131048 (2021).","journal-title":"Hepatology"},{"issue":"3","key":"86674_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","volume":"53","author":"EASL clinical practice guidelines on the","year":"2010","unstructured":"EASL clinical practice guidelines on the. Management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J. Hepatol. 53(3), 397\u2013417 (2010).","journal-title":"J. Hepatol."},{"issue":"18","key":"86674_CR9","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2023.5997","volume":"329","author":"EB Tapper","year":"2023","unstructured":"Tapper, E. B. & Parikh, N. D. Diagnosis and management of cirrhosis and its complications: A review. Jama 329(18), 1589\u20131602 (2023).","journal-title":"Jama"},{"issue":"9","key":"86674_CR10","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1056\/NEJMoa2008290","volume":"384","author":"F Wong","year":"2021","unstructured":"Wong, F. et al. Terlipressin plus Albumin for the treatment of type 1 Hepatorenal Syndrome. N. Engl. J. Med. 384(9), 818\u2013828 (2021).","journal-title":"N Engl. J. Med."},{"issue":"5","key":"86674_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.beth.2020.05.002","volume":"51","author":"T Jiang","year":"2020","unstructured":"Jiang, T., Gradus, J. L. & Rosellini, A. J. Supervised machine learning: A brief primer. Behav. Ther. 51(5), 675\u2013687 (2020).","journal-title":"Behav. Ther."},{"issue":"1","key":"86674_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener, J. G., Kandathil, S. M., Moffat, L. & Jones, D. T. A guide to machine learning for biologists. Nat. Rev. Mol. Cell. Biol. 23(1), 40\u201355 (2022).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"20","key":"86674_CR13","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/CIRCULATIONAHA.115.001593","volume":"132","author":"RC Deo","year":"2015","unstructured":"Deo, R. C. Machine learning in medicine. Circulation 132(20), 1920\u20131930 (2015).","journal-title":"Circulation"},{"issue":"1","key":"86674_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-022-02618-x","volume":"23","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. Establishment and evaluation of an early prediction model of hepatorenal syndrome in patients with decompensated hepatitis B cirrhosis. BMC Gastroenterol. 23(1), 1 (2023).","journal-title":"BMC Gastroenterol."},{"issue":"11","key":"86674_CR15","doi-asserted-by":"publisher","first-page":"e13393","DOI":"10.1111\/ijcp.13393","volume":"73","author":"JD Koola","year":"2019","unstructured":"Koola, J. D. et al. A clinical risk prediction model to identify patients with hepatorenal syndrome at hospital admission. Int. J. Clin. Pract. 73(11), e13393 (2019).","journal-title":"Int. J. Clin. Pract."},{"issue":"1","key":"86674_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson, A. E. W. et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci. Data. 10(1), 1 (2023).","journal-title":"Sci. Data"},{"key":"86674_CR17","doi-asserted-by":"publisher","first-page":"180178","DOI":"10.1038\/sdata.2018.178","volume":"5","author":"TJ Pollard","year":"2018","unstructured":"Pollard, T. J. et al. The eICU Collaborative Research Database, a freely available multi-center database for critical care research. Sci. Data. 5, 180178 (2018).","journal-title":"Sci. Data"},{"issue":"1","key":"86674_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/24709360.2018.1435608","volume":"2","author":"K Zhu","year":"2017","unstructured":"Zhu, K., Huang, Y. & Zhou, X. H. Tree-based ensemble methods for Individualized treatment rules. Biostat Epidemiol. 2(1), 61\u201383 (2017).","journal-title":"Biostat Epidemiol."},{"issue":"1","key":"86674_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"2018","unstructured":"Tibshirani, R. Regression shrinkage and selection via the Lasso. J. R. Stat. Soc. Ser. B (Methodol.). 58(1), 267\u2013288 (2018).","journal-title":"J. Roy. Stat. Soc.: Ser. B (Methodol.)"},{"key":"86674_CR20","unstructured":"Chen, T. Xgboost: extreme gradient boosting. R package version 04\u2009\u2013\u20092. ;1(4). (2015)."},{"issue":"10s","key":"86674_CR21","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cgh.2023.04.034","volume":"21","author":"D Adebayo","year":"2023","unstructured":"Adebayo, D. & Wong, F. Pathophysiology of hepatorenal syndrome\u2014acute kidney Injury. Clin. Gastroenterol. Hepatol. 21(10s), S1\u2013s10 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"86674_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cnc.2022.04.010","volume":"34","author":"LL Divens","year":"2022","unstructured":"Divens, L. L. & Rivera, S. L. Hepatorenal syndrome: From the beginning to now. Crit. Care Nurs. Clin. N. Am. 34(3), 321\u2013329 (2022).","journal-title":"Crit. Care Nurs. Clin. North. Am."},{"issue":"1","key":"86674_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","volume":"105","author":"A Gin\u00e8s","year":"1993","unstructured":"Gin\u00e8s, A. et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105(1), 229\u2013236 (1993).","journal-title":"Gastroenterology"},{"issue":"4","key":"86674_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.5507\/bp.2015.010","volume":"159","author":"M Janicko","year":"2015","unstructured":"Janicko, M., Veseliny, E., Senajova, G. & Jarcuska, P. Predictors of hepatorenal syndrome in alcoholic liver cirrhosis. Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub. 159(4), 661\u2013665 (2015).","journal-title":"Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"86674_CR25","doi-asserted-by":"crossref","unstructured":"Sasso, R., Abou Yassine, A. & Deeb, L. Predictors of development of hepatorenal syndrome in hospitalized cirrhotic patients with acute kidney Injury. J. Clin. Med. 10(23). (2021).","DOI":"10.3390\/jcm10235621"},{"issue":"3","key":"86674_CR26","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/hep.20146","volume":"39","author":"K Lenz","year":"2004","unstructured":"Lenz, K., Kapral, C., Gegenhuber, A., Buder, R. & Wewalka, F. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 39(3), 865\u2013866 (2004). author reply 6\u20137.","journal-title":"Hepatology"},{"issue":"5","key":"86674_CR27","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","volume":"38","author":"L Ruiz-del-Arbol","year":"2003","unstructured":"Ruiz-del-Arbol, L. et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 38(5), 1210\u20131218 (2003).","journal-title":"Hepatology"},{"issue":"7","key":"86674_CR28","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/MEG.0000000000000635","volume":"28","author":"TA Salman","year":"2016","unstructured":"Salman, T. A., Edrees, A. M., El-Said, H. H., El-Abd, O. L. & El-Azab, G. I. Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis. Eur. J. Gastroenterol. Hepatol. 28(7), 777\u2013785 (2016).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"1","key":"86674_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/1871523022666230613160225","volume":"22","author":"SM El Sharawy","year":"2023","unstructured":"El Sharawy, S. M., Elkadeem, M. Z. & Amer, I. F. The predictors of Hepatorenal Syndrome Development in HCV cirrhotic ascitic Egyptian patients with spontaneous bacterial peritonitis. Antiinflamm. Antiallergy Agents Med. Chem. 22(1), 58\u201366 (2023).","journal-title":"Antiinflamm Antiallergy Agents Med. Chem."},{"issue":"6","key":"86674_CR30","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1002\/hep.23918","volume":"52","author":"P Bellot","year":"2010","unstructured":"Bellot, P. et al. Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology 52(6), 2044\u20132052 (2010).","journal-title":"Hepatology"},{"issue":"2","key":"86674_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1053\/ajkd.2003.50035","volume":"41","author":"DS Sherman","year":"2003","unstructured":"Sherman, D. S., Fish, D. N. & Teitelbaum, I. Assessing renal function in cirrhotic patients: Problems and pitfalls. Am. J. Kidney Dis. 41(2), 269\u2013278 (2003).","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"86674_CR32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","volume":"52","author":"C Francoz","year":"2010","unstructured":"Francoz, C., Glotz, D., Moreau, R. & Durand, F. The evaluation of renal function and disease in patients with cirrhosis. J. Hepatol. 52(4), 605\u2013613 (2010).","journal-title":"J. Hepatol."},{"issue":"116","key":"86674_CR33","first-page":"1168","volume":"59","author":"HS Ahn","year":"2012","unstructured":"Ahn, H. S. et al. Cystatin C is a good predictor of hepatorenal syndrome and survival in patients with cirrhosis who have normal serum creatinine levels. Hepatogastroenterology 59(116), 1168\u20131173 (2012).","journal-title":"Hepatogastroenterology"},{"issue":"10","key":"86674_CR34","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/j.1478-3231.2009.02105.x","volume":"29","author":"YS Seo","year":"2009","unstructured":"Seo, Y. S. et al. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels. Liver Int. 29(10), 1521\u20131527 (2009).","journal-title":"Liver Int."},{"issue":"8","key":"86674_CR35","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/j.1478-3231.2012.02766.x","volume":"32","author":"A Finkenstedt","year":"2012","unstructured":"Finkenstedt, A. et al. Cystatin C is a strong predictor of survival in patients with cirrhosis: Is a cystatin C-based MELD better? Liver Int. 32(8), 1211\u20131216 (2012).","journal-title":"Liver Int."},{"issue":"5","key":"86674_CR36","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/j.1478-3231.2008.01716.x","volume":"28","author":"J Fevery","year":"2008","unstructured":"Fevery, J. Bilirubin in clinical practice: A review. Liver Int. 28(5), 592\u2013605 (2008).","journal-title":"Liver Int."},{"issue":"9","key":"86674_CR37","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.4254\/wjh.v16.i9.1229","volume":"16","author":"OM Fierro-Angulo","year":"2024","unstructured":"Fierro-Angulo, O. M., Gonz\u00e1lez-Regueiro, J. A., Pereira-Garc\u00eda, A., Ruiz-Marg\u00e1in, A. & Solis-Huerta, F. Mac\u00edas-Rodr\u00edguez RU. Hematological abnormalities in liver cirrhosis. World J. Hepatol. 16(9), 1229\u20131244 (2024).","journal-title":"World J. Hepatol."},{"issue":"5","key":"86674_CR38","first-page":"4614","volume":"13","author":"J Peng","year":"2021","unstructured":"Peng, J., He, G., Chen, H. & Kuang, X. Study on correlation between coagulation indexes and disease progression in patients with cirrhosis. Am. J. Transl Res. 13(5), 4614\u20134623 (2021).","journal-title":"Am. J. Transl Res."},{"issue":"5","key":"86674_CR39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1055\/s-0035-1550435","volume":"41","author":"M Hoffman","year":"2015","unstructured":"Hoffman, M. Coagulation in liver disease. Semin Thromb. Hemost. 41(5), 447\u2013454 (2015).","journal-title":"Semin Thromb. Hemost."},{"issue":"7","key":"86674_CR40","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1177\/1535370217693113","volume":"242","author":"Y Lv","year":"2017","unstructured":"Lv, Y. et al. Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly. Exp. Biol. Med. (Maywood). 242(7), 744\u2013749 (2017).","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"1","key":"86674_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.mehy.2010.08.043","volume":"76","author":"G Kalambokis","year":"2011","unstructured":"Kalambokis, G. & Tsianos, E. V. Endotoxaemia in the pathogenesis of cytopenias in liver cirrhosis. Could oral antibiotics raise blood counts? Med. Hypoth. 76(1), 105\u2013109 (2011).","journal-title":"Med. Hypotheses"},{"key":"86674_CR42","doi-asserted-by":"publisher","first-page":"1134744","DOI":"10.1155\/2020\/1134744","volume":"2020","author":"S Bizid","year":"2020","unstructured":"Bizid, S. et al. Does Anemia have a potential effect on type 2 Hepatorenal Syndrome? Can. J. Gastroenterol. Hepatol. 2020, 1134744 (2020).","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"3","key":"86674_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5152\/tjg.2016.16029","volume":"27","author":"G G\u00fcng\u00f6r","year":"2016","unstructured":"G\u00fcng\u00f6r, G. et al. Is there any potential or additive effect of anemia on hepatorenal syndrome? Turk. J. Gastroenterol. 27(3), 273\u2013278 (2016).","journal-title":"Turk. J. Gastroenterol."},{"issue":"3","key":"86674_CR44","doi-asserted-by":"publisher","first-page":"777","DOI":"10.12998\/wjcc.v10.i3.777","volume":"10","author":"M Manrai","year":"2022","unstructured":"Manrai, M., Dawra, S., Kapoor, R., Srivastava, S. & Singh, A. Anemia in cirrhosis: An underestimated entity. World J. Clin. Cases. 10(3), 777\u2013789 (2022).","journal-title":"World J. Clin. Cases"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86674-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86674-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86674-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T01:32:12Z","timestamp":1737509532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86674-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86674"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86674-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"An investigation of anonymized, publically accessible datasets with prior institutional review board permission was the study\u2019s methodology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2743"}}